We previously reported the logistic regression model based on CSF amyloid and Tau levels that correctly classified individuals with clinically probable AD [37] and used this to distinguish age-matched CH individuals with normal amyloid/Tau (CH-NAT) or pathological amyloid/Tau (CH-PAT). The gene discussed is MAPT; the disease is cyclic hematopoiesis.